Rodman&Renshaw Part 2:Rosetta Genomics(ROSG)and Response Genetics(RGDX)
Within the “diagnostics and tools” track at the Rodman and Renshaw Conference here are two interesting genomics companies that presented. Rosetta Genomics Ltd. (ROSG, $1.25) ,Market Cap $21M, Sh.Out. 16.5M Rosetta is an Israeli Company focused in development of microRNA-based...
Rodman&Renshaw Notes Part 2: Sequenom (SQNM)
Sequenom (SQNM) $7, Market Cap $529M, 76M Sh. Outstanding Sequenom presented a financial update and their plans for their T21 trisomy 21 noninvasive pre-natal test for fetal gene and chromosomal abnormalities. The Company plans to launch a CLIA LDT (lab developed test) by Q4 2011 and submit a...
Sierra SnowBlog 2010 La Nina Pattern Next 3 Months: Cold for Northern U.S.
A weather pundit came on CNBC today reiterating La Nina and it impact on energy markets beginning in November. He is forecasting cold weather for the Northern tier in the U.S. (see below).
Watch Nat Gas come off its lows to low $4 range, now trading at $3.935.
Also The Rayno Report has a ski clip and a story from the latest Powder magazine on boutique ski gear.
Climate Prediction Center: ENSO Diagnostic Discussion
The Rayno Report | Ski Revolution!
Rodman&Renshaw Notes Part 2: Adeon(AEN)and Exact Sciences(EXAS)
Continuing from Part 1 here are some specific comments on interesting companies. Adeona Pharmaceuticals (AEN) Amex ($0.83) Market Cap $19M, $25M Sh. Outstanding Adeona is a development stage drug Company focused in CNS that in -licenses clinical stage product candidates that are ready to be...
Notes from the Rodman&Renshaw Global Investment Conference-Part1
We attended the R&R Conference in NYC this week and here is a brief summary: Over 5000 people were registered with hundreds of companies presenting in healthcare, metals and mining,energy and China. Chinese companies were a significant presence for the first time this year.A major report...
